实用医学杂志
實用醫學雜誌
실용의학잡지
THE JOURNAL OF PRACTICAL MEDICINE
2014年
5期
719-722
,共4页
棘球蚴病,肝%白细胞介素-17%白细胞介素-10
棘毬蚴病,肝%白細胞介素-17%白細胞介素-10
극구유병,간%백세포개소-17%백세포개소-10
Echinococcosis,hepatic%IL-17%IL-10
目的:探讨不同类型肝囊型包虫病(CE)患者外周血中白细胞介素-17(IL-17)、白细胞介素-10(IL-10)在疾病发展过程中的作用及对囊肿生物活性判断的价值。方法:将33例CE患者和21例健康体检者按WHO的囊型包虫病B超分类原则共分为4组:健康对照组21例,Ⅰ、Ⅱ型包虫病组14例,Ⅲ型包虫病组10例,Ⅳ、Ⅴ型包虫病组9例。采用酶联免疫吸附法(ELISA法)检测各组IL-17、IL-10的表达。结果:Ⅲ型包虫病组IL-17水平显著高于其他各型包虫病组,差异有统计学意义(P<0.05);Ⅰ、Ⅱ型包虫病组IL-17水平[(38.57±3.83) pg/mL]与Ⅳ、Ⅴ型包虫病组[(40.22±5.15) pg/mL]比较无明显差异。Ⅲ型包虫病组IL-10水平[(14.65±2.15) pg/mL]显著高于Ⅰ、Ⅱ型包虫病组[(11.38±0.71) pg/mL],Ⅰ、Ⅱ型包虫病组IL-10水平显著高于Ⅳ、Ⅴ型包虫病组[(7.60±0.46) pg/mL],差异有统计学意义(P<0.05);Ⅰ、Ⅱ型包虫病组IL-17/IL-10(3.44±1.04)与Ⅲ型包虫病组(4.60±2.40)相比较无明显差异,Ⅲ型包虫病组IL-17/IL-10与Ⅳ、Ⅴ型包虫病组(5.39±1.95)相比较无明显差异,Ⅰ、Ⅱ型包虫病组IL-17/IL-10显著低于Ⅳ、Ⅴ型包虫病组(P<0.05)。结论:IL-17、IL-10相互协同在促进CE自然病程发展中可能起到一定作用,IL-17和IL-10不能单独作为判断包虫囊肿活性的指标;IL-17/IL-10在一定程度上反应了包虫囊肿的活性,但作为判断各型肝囊型包虫囊肿的活性指标有待进一步讨论验证。
目的:探討不同類型肝囊型包蟲病(CE)患者外週血中白細胞介素-17(IL-17)、白細胞介素-10(IL-10)在疾病髮展過程中的作用及對囊腫生物活性判斷的價值。方法:將33例CE患者和21例健康體檢者按WHO的囊型包蟲病B超分類原則共分為4組:健康對照組21例,Ⅰ、Ⅱ型包蟲病組14例,Ⅲ型包蟲病組10例,Ⅳ、Ⅴ型包蟲病組9例。採用酶聯免疫吸附法(ELISA法)檢測各組IL-17、IL-10的錶達。結果:Ⅲ型包蟲病組IL-17水平顯著高于其他各型包蟲病組,差異有統計學意義(P<0.05);Ⅰ、Ⅱ型包蟲病組IL-17水平[(38.57±3.83) pg/mL]與Ⅳ、Ⅴ型包蟲病組[(40.22±5.15) pg/mL]比較無明顯差異。Ⅲ型包蟲病組IL-10水平[(14.65±2.15) pg/mL]顯著高于Ⅰ、Ⅱ型包蟲病組[(11.38±0.71) pg/mL],Ⅰ、Ⅱ型包蟲病組IL-10水平顯著高于Ⅳ、Ⅴ型包蟲病組[(7.60±0.46) pg/mL],差異有統計學意義(P<0.05);Ⅰ、Ⅱ型包蟲病組IL-17/IL-10(3.44±1.04)與Ⅲ型包蟲病組(4.60±2.40)相比較無明顯差異,Ⅲ型包蟲病組IL-17/IL-10與Ⅳ、Ⅴ型包蟲病組(5.39±1.95)相比較無明顯差異,Ⅰ、Ⅱ型包蟲病組IL-17/IL-10顯著低于Ⅳ、Ⅴ型包蟲病組(P<0.05)。結論:IL-17、IL-10相互協同在促進CE自然病程髮展中可能起到一定作用,IL-17和IL-10不能單獨作為判斷包蟲囊腫活性的指標;IL-17/IL-10在一定程度上反應瞭包蟲囊腫的活性,但作為判斷各型肝囊型包蟲囊腫的活性指標有待進一步討論驗證。
목적:탐토불동류형간낭형포충병(CE)환자외주혈중백세포개소-17(IL-17)、백세포개소-10(IL-10)재질병발전과정중적작용급대낭종생물활성판단적개치。방법:장33례CE환자화21례건강체검자안WHO적낭형포충병B초분류원칙공분위4조:건강대조조21례,Ⅰ、Ⅱ형포충병조14례,Ⅲ형포충병조10례,Ⅳ、Ⅴ형포충병조9례。채용매련면역흡부법(ELISA법)검측각조IL-17、IL-10적표체。결과:Ⅲ형포충병조IL-17수평현저고우기타각형포충병조,차이유통계학의의(P<0.05);Ⅰ、Ⅱ형포충병조IL-17수평[(38.57±3.83) pg/mL]여Ⅳ、Ⅴ형포충병조[(40.22±5.15) pg/mL]비교무명현차이。Ⅲ형포충병조IL-10수평[(14.65±2.15) pg/mL]현저고우Ⅰ、Ⅱ형포충병조[(11.38±0.71) pg/mL],Ⅰ、Ⅱ형포충병조IL-10수평현저고우Ⅳ、Ⅴ형포충병조[(7.60±0.46) pg/mL],차이유통계학의의(P<0.05);Ⅰ、Ⅱ형포충병조IL-17/IL-10(3.44±1.04)여Ⅲ형포충병조(4.60±2.40)상비교무명현차이,Ⅲ형포충병조IL-17/IL-10여Ⅳ、Ⅴ형포충병조(5.39±1.95)상비교무명현차이,Ⅰ、Ⅱ형포충병조IL-17/IL-10현저저우Ⅳ、Ⅴ형포충병조(P<0.05)。결론:IL-17、IL-10상호협동재촉진CE자연병정발전중가능기도일정작용,IL-17화IL-10불능단독작위판단포충낭종활성적지표;IL-17/IL-10재일정정도상반응료포충낭종적활성,단작위판단각형간낭형포충낭종적활성지표유대진일보토론험증。
Objective To explore the significance of IL-17 and IL-10 in patients with different types of hepatic cystic echinococcosis ( CE ) in cyst stages , to investigate the values of evaluation of hydatid cyst activity . Methods 33 patients with hepatic hydatid disease and 21 healthy people (control group) were enrolled, divided into 4 groups, according to WHO ultrasonic classification for CE:Control group (n=21), CEⅠ,Ⅱgroup (active, n=14), CEⅢgroup (transitional, n=10), and CEⅣ,Ⅴgroup (inactive, n=9). The serum concentrations of IL-17 and IL-10 were measured by enzyme-linked immunosorbent assay. Results Serum levels of IL-17 in CEⅢgroup were significantly higher than other groups (P<0.05). There were no significant difference in serum IL-17 levels between CEⅠ,Ⅱgroup [(38.57 ± 3.83) pg/mL] and CEⅣ,Ⅴgroup [(40.22 ± 5.15) pg/mL]. Serum levels of IL-10 were significantly higher in CEⅢgroup [(14.65 ± 2.15) pg/mL] than CEⅠ,Ⅱgroup [(11.38 ± 0.71) pg/mL] (P<0.05), while CEⅠ,Ⅱgroup were significantly higher than CEⅣ,Ⅴgroup [(7.60 ± 0.46) pg/mL] (P<0.05). There were no significant difference of IL-17/IL-10 ratio between CEⅠ, Ⅱgroup (3.44 ± 1.04) and CEⅢgroup (4.60 ± 2.40), and there were no significant difference of IL-17/IL-10 ratio between CEⅢgroup and CEⅣ,Ⅴgroup (5.39 ± 1.95). IL-17/IL-10 ratio in CEⅠ, Ⅱgroup was significantly lower than CEⅣ, Ⅴgroup (P<0.05). The serum concentrations of IL-17 has no correlation with IL-10 in different cyst stages. Conclusions The synergy effect of IL-17 and IL-10 may play the certain role to promote the parasite progress. Neither IL-17 nor IL-10 level could be as an independent marker of echinococcal cysts activity, while IL-17/IL-10 ratio reflect the hydatid cyst activity in certain degree, but as a echinococcal cysts activity marker, further evidence should be needed.